FY19 estimates are just that, estimates (my opinion based on reading the reports and my thoughts on the business). In no way is it financial advice or to be construed as fact. 35M profit is based on what I think is achievable given past performance and management's outlook/strategy as well as current business environment. You're welcome to disagree and that's completely fair.
All figures/numbers are taken from reports released by the company. I do note in some cases I may have rounded slightly and there is variation due to 52/53 week years which may not be accounted for accurately. It's a big picture overview not meant to be accurate to the dollar, I'm not reconciling their books.
Regarding the margin, I think I was getting tired at that point and confess that number is wrong on second look - it should be 56.3% I think I read the retail margin not group. I apologise.
- Forums
- ASX - By Stock
- GXL
- Ann: FY18 Full Year Results - Investor Presentation
Ann: FY18 Full Year Results - Investor Presentation, page-35
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online